Healthcare Realty Trust Incorporated $HR Position Increased by Sequoia Financial Advisors LLC

Key Points

• Sequoia Financial Advisors increased its stake in Healthcare Realty Trust by 139.6% during the second quarter, bringing its total holdings to 35,475 shares valued at $563,000.
• Healthcare Realty Trust's stock has seen fluctuations, with a one-year low of $14.09 and a high of $18.82, currently trading at $18.60.
• The company recently cut its dividend to $0.24 per share, reflecting a significant negative payout ratio of -83.48%.

Sequoia Financial Advisors LLC increased its stake in Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) by 139.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 35,475 shares of the real estate investment trust's stock after purchasing an additional 20,672 shares during the period. Sequoia Financial Advisors LLC's holdings in Healthcare Realty Trust were worth $563,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Golden State Wealth Management LLC bought a new stake in shares of Healthcare Realty Trust in the 1st quarter worth approximately $26,000. SVB Wealth LLC bought a new stake in Healthcare Realty Trust during the 1st quarter valued at $35,000. Anchor Investment Management LLC bought a new stake in Healthcare Realty Trust during the 1st quarter valued at $38,000. Financial Gravity Asset Management Inc. bought a new stake in Healthcare Realty Trust during the 1st quarter valued at $48,000. Finally, Avalon Trust Co bought a new stake in Healthcare Realty Trust during the 1st quarter valued at $53,000.

Healthcare Realty Trust Stock Performance

HR opened at $18.60 on Monday. Healthcare Realty Trust Incorporated has a one year low of $14.09 and a one year high of $18.82. The stock's fifty day moving average is $17.63 and its 200-day moving average is $16.22. The company has a market capitalization of $6.54 billion, a PE ratio of -16.17 and a beta of 0.96.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Healthcare Realty Trust had a negative return on equity of 7.70% and a negative net margin of 32.95%.The company had revenue of $287.07 million for the quarter, compared to the consensus estimate of $290.83 million. During the same quarter in the previous year, the business earned $0.38 EPS. Healthcare Realty Trust has set its FY 2025 guidance at 1.570-1.610 EPS. On average, equities research analysts forecast that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current fiscal year.

Healthcare Realty Trust Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Thursday, August 14th were paid a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a dividend yield of 5.2%. The ex-dividend date of this dividend was Thursday, August 14th. Healthcare Realty Trust's payout ratio is currently -83.48%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on HR shares. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Healthcare Realty Trust in a research note on Wednesday, October 8th. BTIG Research reaffirmed a "buy" rating and set a $20.00 target price on shares of Healthcare Realty Trust in a research note on Monday, September 29th. Wells Fargo & Company increased their price objective on shares of Healthcare Realty Trust from $15.00 to $16.00 and gave the company an "underweight" rating in a report on Wednesday, August 27th. Scotiabank upgraded shares of Healthcare Realty Trust from a "sector perform" rating to a "sector outperform" rating and increased their price objective for the company from $18.00 to $20.00 in a report on Friday, September 5th. Finally, Royal Bank Of Canada began coverage on shares of Healthcare Realty Trust in a report on Wednesday, October 8th. They issued a "sector perform" rating and a $19.00 price objective for the company. Three investment analysts have rated the stock with a Buy rating, four have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, Healthcare Realty Trust has a consensus rating of "Hold" and a consensus price target of $18.50.

Insiders Place Their Bets

In related news, EVP Julie F. Wilson sold 15,000 shares of Healthcare Realty Trust stock in a transaction on Friday, September 5th. The stock was sold at an average price of $18.00, for a total value of $270,000.00. Following the transaction, the executive vice president directly owned 113,419 shares in the company, valued at $2,041,542. The trade was a 11.68% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Thomas N. Bohjalian bought 10,000 shares of the firm's stock in a transaction that occurred on Wednesday, August 13th. The stock was bought at an average price of $16.46 per share, for a total transaction of $164,600.00. Following the completion of the acquisition, the director directly owned 75,520 shares in the company, valued at approximately $1,243,059.20. The trade was a 15.26% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 0.37% of the company's stock.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.